Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Remix this Asset

Precision CRISPR detection

01

Uses CRISPR-Cas systems for ultra-specific and sensitive detection of microbial and viral signatures.

Real-Time resistance mapping

02

Targets antimicrobial resistance profiles, enabling clinicians to respond with precision therapies.

Portable & Scalable

03

Microfluidic design allows for rapid, low-cost deployment in labs, clinics, or mobile health units.

Modular bioscience, at your fingertips